FIELD: medicine, pharmaceutics.
SUBSTANCE: in formula 1 X represents N or CR, and Y represents N or CH on condition that X and Y are not simultaneously carbon; Z represents N or CH; R1 and R2 represent independently hydrogen, (C3-C10)cycloalkyl, norbornyl, adamantyl or noradamantyl, or R1 and R2 can be bound with each other together with nitrogen atoms, to which they are bound, with the formation of (C5-C10) saturated or unsaturated heterocycle or condensed heterocycle, on condition that R1 and R2 are not simultaneously hydrogen; L represents a single bond, -CO-, -SO2-, -(CR21R22)-(CH2)c- (c represents an integer number 0-5), , -CO(CR21R22)d- (d represents an integer number 1-6), (C3-C10)cycloalkylene, (C6-C20)arylene or 5-6-membered heteroarylene, including one or two heteroatoms, selected from N; R21 and R22 represent independently hydrogen or (C1-C10)alkyl, R represents hydrogen or hydroxyl; R4 and R5 independently represent hydrogen or (C1-C10)alkyl, or R4 and R5, bound together form a 6-membered unsaturated carbocycle; R6 and R7 represent independently hydrogen, (C1-C10)alkyl or halogen; R31-R38, R41-R43 and R46 represent independently hydrogen or (C1-C10)alkyl; and m and n independently represent an integer number 0-3 on condition that m+n represent an integer number 2 or larger. Values of radical R3 and additional substituents of cyclic groups R1-R3, L are given in the invention formula. The invention also relates to pharmaceutical composition, containing the said compounds, and to the 11β-HSD1 inhibitor.
.
EFFECT: invention relates to amide compounds of structural formula 1, which possess inhibiting activity with respect to 11β-HSD1 enzyme.
9 cl, 24 tbl, 296 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING | 2001 |
|
RU2263676C2 |
2-PYRIDYL SUBSTITUTED IMIDAZOLES AS ALK5 AND/OR ALK4 INHIBITORS | 2012 |
|
RU2612958C2 |
NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2366659C2 |
TRICYCLIC NITROGEN-CONTAINING DERIVATIVES OF IMIDAZO[4,5-C]PYRIDINE, HAVING INHIBITING ACTIVITY IN RESPONSE TO HYSTAMINE 4 RECEPTOR (HH4R) | 2012 |
|
RU2628074C2 |
NEW COMPOUNDS FOR SELECTIVE HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL COMPOSITION INCLUDING SUCH COMPOUNDS | 2014 |
|
RU2634694C2 |
DERIVATIVES OF IMIDAZOLE ELICITING INHIBITORY ACTIVITY WITH RESPECT TO FARNESYLTRANSFERASE, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2179975C1 |
COMPOUNDS AND COMPOSITIONS FOR MODULATING KINASE ACTIVITY OF EGFR MUTANTS | 2015 |
|
RU2822389C2 |
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2598852C2 |
MELANOCORTIN RECEPTOR AGONISTS | 2007 |
|
RU2411240C2 |
Authors
Dates
2015-10-27—Published
2011-05-04—Filed